SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-07-011081
Filing Date
2007-08-08
Accepted
2007-08-08 16:39:10
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y37365e10vq.htm 10-Q 481102
2 EX-10.1: AMENDED AND RESTATED INCENTIVE PLAN y37365exv10w1.htm EX-10.1 59857
3 EX-10.2: FORM OF BOARD OF DIRECTORS RESTRICTED STOCK AGREEMENT y37365exv10w2.htm EX-10.2 19055
4 EX-10.3: FORM OF BOARD OF DIRECTORS NON-QUALIFIED STOCK OPTION AGREEMENT y37365exv10w3.htm EX-10.3 21839
5 EX-31.1: CERTIFICATION y37365exv31w1.htm EX-31.1 8533
6 EX-31.2: CERTIFICATION y37365exv31w2.htm EX-31.2 8499
7 EX-32.1: CERTIFICATION y37365exv32w1.htm EX-32.1 3146
8 EX-32.2: CERTIFICATION y37365exv32w2.htm EX-32.2 3099
  Complete submission text file 0000950123-07-011081.txt   606640
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15313 | Film No.: 071036146
SIC: 2833 Medicinal Chemicals & Botanical Products